Both in Biotechnology
Maze Therapeutics vs BioCryst Pharmaceuticals
Over the past year MAZE returned −3.0% and BCRX returned +24.9%; their daily moves had a correlation of 0.23.
MAZE −3.0% BCRX +24.9%Growth of $1, one year, split-adjusted
| Metric | MAZE | BCRX |
|---|---|---|
| Price | $32.25 | $8.57 |
| Market cap | $1.79B | $2.19B |
| Today | +6.19% | +3.94% |
| 1 month | +22.0% | +5.8% |
| 6 months | +21.4% | −5.1% |
| Year to date | −22.2% | +9.9% |
| 1 year | −2.0% | +17.1% |
| Revenue growth (YoY) | — | +33.6% |
| Gross margin | — | 98.2% |
| Net margin | — | 35.9% |
| P/E (TTM) | — | — |
| Price / sales | 89.6× | 2.3× |
| Net cash | $372.1M | -$471.6M |
| Dividend yield | — | — |
| Volatility (60d) | 67.4% | 44.9% |
| Short % of float | 18.8% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).